Effectiveness Chronic Kidney Disease & Therapeutic Exercise

Effectiveness and Safety of the Therapeutic Exercise in Patients With Chronic Kidney Disease

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03416140

Enrollment

Registered

2018-01-30

Start date

2018-02-15

Completion date

2021-06-15

Last updated

2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise, Kidney Diseases

Brief summary

The purpose of this study is to assess the effectiveness and safety of the therapeutic exercise effects in patients with chronic kidney disease. An randomized clinical trial is carried out. A total sample of 70 patients with chronic kidney disease is recruited and divided into a therapeutic exercise group and a control group. The kidney function (creatinine clearance as main outcome) is measured at baseline and 1 month after treatment start.

Interventions

OTHERTherapeutic Exercise

30 minutes per day of therapeutic exercise

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with chronic kidney disease

Exclusion criteria

* Cognitive impairment and non signed consent inform form

Design outcomes

Primary

Measure	Time frame	Description
Kidney function	Change from Baseline creatinine clearance at 1 month	Creatinine clearance

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026